The impact of platelet glycoprotein IIIa and la polymorphisms in cardiovascular thrombotic disease

Italian Heart Journal

Volumn 4, Issue 1, 2003, Pages 17-22

  Charakida, Marietta ^a   Tousoulis, Dimitris ^a   Stefanadis, Christodoulos ^a   Toutouzas, Pavlos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Acute coronary syndrome; Platelets; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCOPROTEIN IIIA; LEUCINE; PROLINE; THROMBOCYTE RECEPTOR; VERY LATE ACTIVATION ANTIGEN 2;

ALLELE; AMINO ACID SUBSTITUTION; CORONARY ARTERY THROMBOSIS; DRUG EFFICACY; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; POINT MUTATION; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; REVIEW; RISK FACTOR; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOGENICITY;

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASES; CORONARY THROMBOSIS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INTEGRIN ALPHA2; INTEGRIN BETA3; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION;

EID: 0037950553     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Henderson A. Coronary heart disease: overview. Lancet 1996; 348 (Suppl 1): S1-S4.
2. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1276-82.
3. Hennekens CH. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation 1998; 97: 1095-102.
4. Wannamethee G, Shaper AG, Macfarlane PW, Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation 1995; 91: 1749-56.
5. Bray PF. Integrin polymorphisms as risk factors for thrombosis. Thromb Haemost 1999; 82: 337-44.
6. Reiner AP, Siscovick DS, Rosendaal FR. Platelet glycoprotein gene polymorphisms and risk of thrombosis: facts and fancies. Rev Clin Exp Hematol 2001; 5: 262-87.
7. Andrews RK, Shen Y, Gardiner EE, Berndt MC. Platelet adhesion receptors and (patho)physiological thrombus formation. Histol Histopathol 2001; 16: 969-80.
8. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998; 94: 657-66.
9. Nurden AT. Polymorphisms of human platelet membrane glycoproteins: structure and clinical significance. Thromb Haemost 1995; 74: 345-51.
10. French DL, Seligsohn U. Platelet glycoprotein IIb/IIIa receptors and Glanzmann's thrombasthenia. Arterioscler Thromb Vasc Biol 2000; 20: 607-10.
11. 3. Blood 1999; 94: 2039-47.
12. Newman PJ. Nomenclature of human platelet alloantigens: a problem with the HPA system? Blood 1994; 83: 1447-51.
13. A2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989; 83: 1778-81.
14. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996; 334: 1090-4.
15. A2 allele and incidence of coronary heart disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2000; 102: 1901-5.
16. Ardissino D, Mannucci PM, Merlini PA, et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 1999; 94: 46-51.
17. Bottiger C, Kastrati A, Koch W, et al. HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 2000; 83: 559-62.
18. A polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bβ 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation 1997; 96: 1424-31.
19. A polymorphism in young men with myocardial infarction. Lancet 1996; 348: 485-6.
20. A2 and coronary risk: a meta-analysis. Thromb Haemost 2001; 85: 626-33.
21. Kekomaki S, Hamalainen L, Kauppinen-Makelin R, Palomaki H, Kaste M, Kontula K. Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. J Cardiovasc Risk 1999; 6: 13-7.
22. A polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscler Thromb Vasc Biol 1999; 19: 2573-8.
23. A1/A2 polymorphism and sudden cardiac death. J Am Coll Cardiol 2000; 36: 1317-23.
24. Pastinen T, Perola M, Niini P, et al. Array-based multiplex analysis of candidate genes reveals two independent and additive genetic risk factors for myocardial infarction in the Finnish population. Hum Mol Genet 1998; 7: 1453-62.
25. Reiner AP, Schwartz SM, Kumar PN, et al. Platelet glycoprotein IIb polymorphism, traditional risk factors and nonfatal myocardial infarction in young women. Br J Haematol 2001; 112: 632-6.
26. Siscovick DS, Schwartz SM, Rosendaal FR, Psaty BM. Thrombosis in the young: effect of atherosclerotic risk factors on the risk of myocardial infarction associated with prothrombotic factors. Thromb Haemost 1997; 78: 7-12.
27. A1/A2 polymorphism with myocardial infarction. Am J Cardiol 2000; 86: 1000-5.
28. A2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. Thromb Haemost 1998; 79: 731-5.
29. A polymorphism and coronary artery disease or carotid intima-media thickness. Thromb Res 1998; 89: 85-9.
30. Walter DH, Schachinger V, Elsner M, Dimmeler S, Zeiher AM. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 1997; 350: 1217-9.
31. A polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation 1999; 99: 1005-10.
32. Laule M, Cascorbi I, Stangl V, et al. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study. Lancet 1999; 353: 708-12.
33. A1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Thromb Haemost 1998; 80: 214-7.
34. A1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 2000; 110: 965-7.
35. Undas A, Sanak M, Musial J, Szczeklik A. Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet 1999; 353: 982-3.
36. 3 enhances outside-in signaling and adhesive functions. J Clin Invest 2000; 105: 793-802.
37. A2 polymorphism: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1999; 19: 1142-7.
38. A2 polymorphism. Br J Haematol 1997; 99: 801-7.
39. A polymorphisms display different sensitivities to agonists. Circulation 2000; 101: 1013-8.
40. 3-integrins in platelets. Blood 2001; 97: 3093-9.
41. A2, Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 1999; 20: 742-7.
42. A2 polymorphism and efficacy of aspirin. (letter) Lancet 1998; 351: 1253.
43. Cannon CP, McCabe CH, Wilcox RG, et al. Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. Circulation 2000; 102: 149-56.
44. O'Connor FF, Shields DC, Fitzgerald A, Cannon CP, Braunwald E, Fitzgerald DJ. Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes. Blood 2001; 98: 3256-60.
45. O'Neill WW, Serruys P, Knudtson M, et al. Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events. N Engl J Med 2000; 342: 1316-24.
46. ++-dependent adhesion of platelets to collagen. J Cell Biol 1989; 108: 1917-24.
47. 1 density. Blood 1998; 92: 2382-8.
48. 1 activity on human platelets. Blood 1993; 82: 2693-703.
49. 2 subunit (platelet GPIa): homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 1989; 109: 397-407.
50. 2 gene coding sequence. Blood 1997; 89: 1939-43.
51. 2). J Clin Invest 1993; 92: 2427-32.
52. Corral J, Rivera J, Gonzalez-Conejero R, Vicente V. The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA-5 polymorphisms. Transfusion 1999; 39: 372-8.
53. 2 integrin) allele frequencies in three North American populations reveals genetic association between nucleotide 807C/T and amino acid 505 Glu/Lys (HPA-5) dimorphisms. Thromb Haemost 1998; 80: 449-56.
54. 2 gene in platelet GP Ia collagen receptor expression and function - effect in thromboembolic diseases. Thromb Haemost 1999; 81: 951-6.
55. Carlsson LE, Greinacher A, Spitzer C, Walther R, Kessler C. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke 1997; 28: 1392-5.
56. 2 subunit of VLA-2). Br J Haematol 1994; 86: 671-4.
57. 2-807 in malignant arrhythmia in coronary artery disease. Tbromb Res 2000; 98: 281-6.
58. 1 might be a genetic risk factor for the development of stroke in younger patients. Blood 1999; 93: 3583-6.
59. Casorelli I, De Stefano V, Leone AM, et al. The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population. Br J Haematol 2001; 114: 150-4.
60. Croft SA, Hampton KK, Sorrell JA, et al. The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction. Br J Haematol 1999; 106: 771-6.
61. Hato T, Minamoto Y, Fukuyama T, Fujita S. Polymorphisms of HPA-1 through 6 on platelet membrane glycoprotein receptors are not a genetic risk factor for myocardial infarction in the Japanese population. Am J Cardiol 1997; 80: 1222-4.
62. Kroll H, Gardemann A, Fechter A, Haberbosch W, Santoso S. The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction. Thromb Haemost 2000; 83: 392-6.
63. Meisel C, Cascorbi I, Herrmann A, et al. The platelet glycoprotein Ia C807T polymorphism as risk factor for coronary catheter interventions. Blood 2000; 96: 2002-3.
64. Morita H, Kurihara H, Imai Y, et al. Lack of association between the platelet glycoprotein Ia C807T gene polymorphism and myocardial infarction in Japanese. An approach entailing melting curve analysis with specific fluorescent hybridization probes. Thromb Haemost 2001; 85: 226-30.
65. Moshfegh K, Wuillemin WA, Redondo M, et al. Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 1999; 353: 351-4.
66. Reiner AP, Kumar PN, Schwartz SM, et al. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 2000; 31: 1628-33.
67. 1 is associated with increased risk of cardiovascular mortality in high-risk women. Circulation 2000; 102: 1645-50.
68. Santoso S, Kunicki TJ, Kroll H, Haberbosch W, Gardemann A. Association of the platelet glycoprotein Ia C807T gene polymorphism with nonfatal myocardial infarction in younger patients. Blood 1999; 93: 2449-53.
69. Sperr WR, Huber K, Roden M, et al. Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans. Thromb Res 1998; 90: 117-23.
70. von Beckerath N, Koch W, Mehilli J, et al. Glycoprotein Ia C807T polymorphism and risk of restenosis following coronary stenting. Atherosclerosis 2001; 156: 463-8.